Comparison of Two Rhythm of Administration of Prostaglandin Gel for Induction of Labor

Labor Complication Clinical Trial

— GELFREQ  

Official title:

Administration of Prostaglandin Gel for Cervical Priming During Induction of Labour Every 12 Hours Versus 24 Hours: a Randomized Superiority Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04413890
• Other study ID #: 19_RIPH2_10
• Status: Completed
• Phase: Phase 2
• Start date: December 17, 2019
• Est. completion date: January 27, 2021

Study information

• Verified date: July 2023
• Source: University Hospital Center of Martinique
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The study compares two rhythms of administration of prostaglandin vaginal gels for cervical priming before induction of labor in term patients. In our institution, prostaglandin gels are given for a maximum of three times, with induction by oxytocin and amniotomy the day after the last gel whatever Bishop score has been obtained. This management results in some patient spending four days in hospital before delivery. The aim of the study is to compare our classical management scheme with a reduced interval between to gels, of 12h instead of 24 h. The primary outcome will be the time elapsed between the first prostaglandin gel and delivery. Tolerance of both management patterns will also be evaluated through a satisfaction survey.

Description:

Approximatively 22% of pregnant women have an induction of labor in France (22.9% in our institution in 2019), mainly for prolonged pregnancy after 41 weeks gestational age or prolonged rupture of membranes. Patients whose cervix is considered unripe (Bishop score under 6) are generally proposed a cervical priming because induction of labor without prior priming entails a higher of cesarean delivery rate for failed induction. The devices used for cervical priming are pharmacological (mainly prostaglandin gel, pessaries or suppositories) or mechanical (Foley catheter, Cook balloons). Very few recommendations exist regarding the type of device, the rhythm and maximal number of repeat administrations and the interval between two administrations. Shortening interval between two administrations (in case of use of a device necessitating serial prescriptions) may shorten the time interval between beginning of priming and delivery. In our institution, a vaginal gel can be given three times before induction of labor with oxytocin and amniotomy, whatever Bishop score has been obtained after priming. These gels are given on a daily basis. This rhythm implies than for some women not responding to a first gel, priming can last up to three days, lengthening hospital stay and leading to maternal weariness. Maternal satisfaction during induction of labor is seldom analyzed. An intensification in gel administration implies a change in maternal management during the induction process, with shortened periods of rest between two gels and nearer periods of pain and discomfort, albeit on a theoretically shorter period. The way patients deal with this new rhythm compared to the classical in part of the evaluation in this study. All patients having a singleton pregnancy and an indication for term (≥ 37 weeks gestation age) induction with an unfavorable cervix and no contraindication to vaginal delivery will be eligible. Patients with fetuses in breech presentation, a scarred uterus, under 18 years, bearing a fetus with antenatally known malformation, not fluent in French or presenting an allergy to prostaglandins will be excluded. A written informed consent will be required before inclusion. The primary outcome will be the duration between first priming with prostaglandin gel and delivery. Secondary outcomes will be the satisfaction of patients with their induction process (measured through a survey answered during the in-hospital post-partum stay), the rate of cesarean section, the rate of hypertonia/hypercinesia during priming and induction requiring medical intervention, the length of active phase of labor (after 5 cm of dilation), the oxytocin doses used during delivery for induction or augmentation, initial neonatal (Apgar score, arterial cord pH and lactates, resuscitation maneuvers, transfer to intensive care unit) and maternal (post-partum hemorrhage, hyperthermia during labor, perineal laceration > 2nd degree and endometritis) morbidity and length of total hospital stay. The investigators calculated that a sample of 268 patients (134 in each group) will be necessary to detect a 30% reduction in duration between first priming and delivery in the experimental group (one gel every 12h) compared with the classical group. Mean time frame between first priming and delivery has been measured in our department in 2018 to 31.8 hours (standard deviation 27.6 hours).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 268
• Est. completion date: January 27, 2021
• Est. primary completion date: January 27, 2021
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 49 Years

Eligibility

Inclusion Criteria:

• Patients above 18 years

• Gestational age = 37 weeks

• With indicated induction of labor and initial Bishop score under 6

• Without any contraindication to vaginal delivery

• Who consent to participate to the clinical research

• With French Medical Public Insurance

Exclusion Criteria:

• Multiple pregnancy

• Previous uterine scar (for myomas or cesarean section)

• Fetus not in cephalic presentation

• Allergy to prostaglandins

• Who not consent to participate to the study

Related Conditions & MeSH terms

• Cervix
• Labor Complication
• Obstetric Labor Complications

Intervention

Drug:
• Dinoprostone vaginal gel
Prostaglandin gel 0.5, 1 or 2 mg

Locations

Country	Name	City	State
Martinique	University Hospital of Martinique	Fort-de-France

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital Center of Martinique

Country where clinical trial is conducted

Martinique, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time between gel administration and delivery	Time between first gel administration for cervical priming and delivery	At inclusion (Day 0)
Primary	Time between gel administration and delivery	Change between cervical priming and delivery	At 12 hours or 24 hours (after each gel administration)
Primary	Time between gel administration and delivery	Time between first gel administration for cervical priming and delivery	Time 0 after the childbirth
Primary	Time between gel administration and delivery	Time between first gel administration for cervical priming and delivery	Until 5 days postpartum (during in-hospital postpartum period)
Secondary	Maternal satisfaction	maternal satisfaction measured by survey self-administered during postpartum hospital stay	Until 5 days postpartum
Secondary	Cesarean section rate		During labor
Secondary	Hypertonia / hypercinesia rate	Hypertonia (rise of uterus tone more than 10 minutes)/hypercinesia (more than 5 uterine contractions per 10 minutes) rate during priming and induction	During priming and induction
Secondary	Oxytocin dose during labor	Induction or augmentation of Oxytocin doses	During labor
Secondary	Length of active first phase of labor	Induction or augmentation of active first phase of labor	During labor
Secondary	Maternal morbidity	Fever during labor, perineal laceration superior to 2nd degree, postpartum hemorrhage, endometritis	During labor
Secondary	Neonatal immediate morbidity	Assess if Apgar score is less than 7	5 minutes after childbirth
Secondary	Neonatal immediate morbidity	Assess of arterial cord pH level	5 minutes after childbirth
Secondary	Neonatal immediate morbidity	Assess of arterial cord lactate level	5 minutes after childbirth
Secondary	Neonatal immediate morbidity	Concentration of arterial cord lactates level (in Mmol/L)	5 minutes after childbirth
Secondary	Neonatal immediate morbidity	Occurence or not of resuscitation maneuvers in delivery room	5 minutes after childbirth
Secondary	Neonatal immediate morbidity	Occurence or no transfer of the child to neonatal intensive care unit	5 minutes after childbirth